Helmut Thomas
Chief Executive Officer at Cyclenium Pharma, Inc.
Helmut Thomas active positions
| Companies | Position | Start | End |
|---|---|---|---|
Cyclenium Pharma, Inc.
 Cyclenium Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cyclenium Pharma, Inc. is a privately held pharmaceutical research and development company based in Montréal, Canada. The Canadian company is focused on creating value through the progression of internal programs in oncology, infectious diseases, and inflammation/pain. Cyclenium is also providing its extensive experience and exploring its CMRT-based Quest™ screening library in risk-sharing partnerships with leading academic and research-driven non-profit organizations, as well as collaborations with innovative pharmaceutical and biotechnology companies worldwide seeking to modulate unique and difficult disease targets in diverse therapeutic areas. The company was founded by Mark L. Peterson, and the CEO is Helmut Thomas. | Chief Executive Officer | - | - |
| Chief Tech/Sci/R&D Officer | - | - | |
| President | - | - |
Career history of Helmut Thomas
Former positions of Helmut Thomas
| Companies | Position | Start | End |
|---|---|---|---|
| OCERA THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 01/06/2006 | - |
| Corporate Officer/Principal | 15/07/2011 | 15/07/2013 | |
Novartis Pharma NV
 Novartis Pharma NV Pharmaceuticals: MajorHealth Technology Founded in 1996, Novartis Pharma NV is a Belgian pharmaceutical company that develops medicines. The company is based in Brussels, Belgium and is a subsidiary of Novartis AG. | Director/Board Member | - | - |
| Ciba-Geigy Corp. | Corporate Officer/Principal | 01/01/1990 | - |
LymphoSign, Inc.
 LymphoSign, Inc. BiotechnologyHealth Technology LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada. | Chief Tech/Sci/R&D Officer | 29/07/2009 | - |
| Corporate Officer/Principal | 01/01/2004 | 29/07/2009 |
Training of Helmut Thomas
| University of Hannover | Doctorate Degree |
Statistics
International
| Canada | 3 |
| United States | 3 |
| Germany | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
LymphoSign, Inc.
LymphoSign, Inc. BiotechnologyHealth Technology LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada. | Health Technology |
Ocera Therapeutics, Inc.
 Ocera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. manufactures pharmaceuticals products. The company was founded in 2004 and is headquartered in Hazelwood, MO. | Health Technology |
| Ciba-Geigy Corp. | Health Technology |
Novartis Pharma NV
Novartis Pharma NV Pharmaceuticals: MajorHealth Technology Founded in 1996, Novartis Pharma NV is a Belgian pharmaceutical company that develops medicines. The company is based in Brussels, Belgium and is a subsidiary of Novartis AG. | Health Technology |
Cyclenium Pharma, Inc.
Cyclenium Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cyclenium Pharma, Inc. is a privately held pharmaceutical research and development company based in Montréal, Canada. The Canadian company is focused on creating value through the progression of internal programs in oncology, infectious diseases, and inflammation/pain. Cyclenium is also providing its extensive experience and exploring its CMRT-based Quest™ screening library in risk-sharing partnerships with leading academic and research-driven non-profit organizations, as well as collaborations with innovative pharmaceutical and biotechnology companies worldwide seeking to modulate unique and difficult disease targets in diverse therapeutic areas. The company was founded by Mark L. Peterson, and the CEO is Helmut Thomas. | Health Technology |
- Stock Market
- Insiders
- Helmut Thomas
- Experience
